146 related articles for article (PubMed ID: 3493845)
21. Establishment of a tumor-specific immunotherapy model utilizing TNP-reactive helper T cell activity and its application to the autochthonous tumor system.
Fujiwara H; Aoki H; Yoshioka T; Tomita S; Ikegami R; Hamaoka T
J Immunol; 1984 Jul; 133(1):509-14. PubMed ID: 6233375
[TBL] [Abstract][Full Text] [Related]
22. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
23. Enhanced TNP-reactive helper T cell activity and its utilization in the induction of amplified tumor immunity that results in tumor regression.
Fujiwara H; Moriyama Y; Suda T; Tsuchida T; Shearer GM; Hamaoka T
J Immunol; 1984 Mar; 132(3):1571-7. PubMed ID: 6198397
[TBL] [Abstract][Full Text] [Related]
24. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
[TBL] [Abstract][Full Text] [Related]
25. Regulatory functions of hapten-reactive helper and suppressor T lymphocytes. III. Amplification of a generation of tumor-specific killer T-lymphocyte activities by suppressor T-cell-depleted hapten-reactive T lymphocytes.
Hamaoka T; Fujiwara H; Teshima K; Aoki H; Yamamoto H; Kitagawa M
J Exp Med; 1979 Jan; 149(1):185-99. PubMed ID: 310858
[TBL] [Abstract][Full Text] [Related]
26. Preventive effect of Propionibacterium acnes on metastasis in mice rendered tolerant to tumor-associated transplantation antigens.
Fujiwara H; Tsuchida T; Tsuji Y; Hamaoka T
Gan; 1980 Oct; 71(5):692-8. PubMed ID: 7248045
[TBL] [Abstract][Full Text] [Related]
27. T-T cell interaction in the in vitro induction of delayed-type hypersensitivity (DTH) responses: demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of DTH responses.
Kosugi A; Takai Y; Ogata M; Fujiwara H; Hamaoka T
J Leukoc Biol; 1985 May; 37(5):629-39. PubMed ID: 3156939
[TBL] [Abstract][Full Text] [Related]
28. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of tumor-bearing state on the generation of in vivo protective immune T cells in a syngeneic murine tumor system.
Fujiwara H; Hamaoka T; Nishino Y; Kitagawa M
Gan; 1977 Oct; 68(5):589-601. PubMed ID: 73490
[TBL] [Abstract][Full Text] [Related]
30. Effect of recombinant interleukin 2 (R-IL2) on in vivo growth of murine myeloma X5563.
Maekawa R; Matsumoto M; Kitagawa T; Harada M; Sato K
Cancer Immunol Immunother; 1986; 23(1):25-30. PubMed ID: 3490306
[TBL] [Abstract][Full Text] [Related]
31. Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.
Izumi Y; Tsuchida T; Okuno K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Sep; 76(9):863-70. PubMed ID: 3932286
[TBL] [Abstract][Full Text] [Related]
32. [The augmentation of tumor-specific immunity by T-T cell interaction].
Fujiwara H; Takai Y; Fukuzawa M; Yoshioka T; Izumi Y; Mizushima Y; Qian J; Ogata M; Kosugi A; Nakajima H
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 2):734-40. PubMed ID: 3157349
[TBL] [Abstract][Full Text] [Related]
33. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. II. Lyt-1+2- T cells have potential to reject antigenically irrelevant (bystander) tumor cells on activation with the specific target tumor cells.
Yoshioka T; Fujiwara H; Takai Y; Ogata M; Shimizu J; Hamaoka T
Cancer Immunol Immunother; 1987; 24(1):8-12. PubMed ID: 3493074
[TBL] [Abstract][Full Text] [Related]
34. Role of cytostasis in antitumor immunity against syngeneic X5563 plasmocytoma: comparative study of cytostasis and cytolysis using variant tumors and neonatally thymectomized mice.
Mitani M; Himeno K; Mori K; Nomoto K
J Clin Lab Immunol; 1989 May; 29(1):45-52. PubMed ID: 2628584
[TBL] [Abstract][Full Text] [Related]
35. Tumor-specific immunotherapy by active immunization with haptenic muramyl dipeptide derivative-coupled tumor cells.
Fujiwara H; Shima J; Sano H; Kosugi A; Nakajima H; Hamaoka T
Prog Clin Biol Res; 1987; 244():335-44. PubMed ID: 2958872
[TBL] [Abstract][Full Text] [Related]
36. The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.
Fujiwara H; Takai Y; Sakamoto K; Hamaoka T
J Immunol; 1985 Sep; 135(3):2187-91. PubMed ID: 3874911
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of Propionibacterium acnes-activated macrophages on the tumor metastasis enhanced by tumor-specific immunosuppression.
Tsuchida T; Fujiwara H; Tsuji Y; Hamaoka T
Gan; 1981 Apr; 72(2):205-12. PubMed ID: 7286546
[TBL] [Abstract][Full Text] [Related]
38. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms for recognition of tumor antigens and mediation of anti-tumor effect by noncytolytic Lyt-2+ T cell subset.
Sakamoto K; Yoshioka T; Shimizu J; Sato S; Nakajima H; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1988 Jan; 79(1):99-108. PubMed ID: 3128511
[TBL] [Abstract][Full Text] [Related]
40. Requirements of adherent cells for activating Lyt-1+2- T cells as well as for functioning as antitumor effectors activated by factor(s) from Lyt-1+2- T cells.
Sakamoto K; Fujiwara H; Nakajima H; Yoshioka T; Takai Y; Hamaoka T
Jpn J Cancer Res; 1986 Nov; 77(11):1142-52. PubMed ID: 3098724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
